drugset / Trial / NCT03670095
Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the release of memantine into the bloodstream of two different formulations: one formulation containing lactose and one without lactose.
Timeline
- Start
- 2018-08-28
- Primary completion
- 2018-12-24
- Completion
- 2018-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 10 mg | Oral |
Indications
No indication recorded.